Browsing Tag
NE3107
1 post
Why targeting ERK and NF-κB pathways may change Parkinson’s disease drug development
Discover how BioVie Inc. is targeting ERK and NF-κB pathways in Parkinson’s disease and what Phase 2 data could mean. Read the full analysis.